|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Anaphore, Inc. Names Former GlaxoSmithKline (GSK) Top Executive Dr. Russell G. Greig as Executive Chairman to Assist in Driving Anaphore's Pipeline of Next Generation Biological Therapies
6/10/2010 9:12:18 AM
LA JOLLA, Calif.--(BUSINESS WIRE)--Anaphore, Inc., an innovative developer of next generation biological therapies, today announced that Russell G. Greig, Ph. D., has joined its Board of Directors as Executive Chairman. Dr. Greig brings an extensive background in all aspects of drug discovery and development, business development, and commercial strategy, as well as first-hand experience working with emerging companies in his most recent role as President of SR One. Dr. Greig’s comprehensive pharmaceutical experience will accelerate the translation of Anaphore’s next generation biological therapies, Atrimers™, into medicines of the future.
|
|
|
|
|
|
|
|
|
|
|